scholarly article | Q13442814 |
P356 | DOI | 10.1378/CHEST.103.2.508 |
P698 | PubMed publication ID | 8432145 |
P2093 | author name string | J M Belsh | |
P L Schiffman | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
P304 | page(s) | 508-513 | |
P577 | publication date | 1993-02-01 | |
P1433 | published in | Chest | Q5093377 |
P1476 | title | Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration | |
P478 | volume | 103 |
Q53198631 | A population based study of respiratory function in motor neuron disease patients living in Tayside and North East Fife, Scotland. |
Q36075065 | Assessment of disease progression in motor neuron disease |
Q90534110 | Associative Increases in Amyotrophic Lateral Sclerosis Survival Duration With Non-invasive Ventilation Initiation and Usage Protocols |
Q48758870 | Bipap improves survival and rate of pulmonary function decline in patients with ALS. |
Q30446869 | Bulbar and speech motor assessment in ALS: challenges and future directions. |
Q33867342 | Capnography for assessing nocturnal hypoventilation and predicting compliance with subsequent noninvasive ventilation in patients with ALS. |
Q92016936 | Classifying Patients with Amyotrophic Lateral Sclerosis by Changes in FVC. A Group-based Trajectory Analysis |
Q35501852 | Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis |
Q62394038 | Development of a patient-specific dyspnoea questionnaire in motor neurone disease (MND): the MND dyspnoea rating scale (MDRS) |
Q28596787 | Diaphragm pacing and motor neurone disease: lessons for all? |
Q64118994 | Diaphragmatic Neurophysiology and Respiratory Markers in ALS |
Q47652452 | Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial |
Q33545071 | Ethical and clinical issues in the use of home non-invasive mechanical ventilation for the palliation of breathlessness in motor neurone disease |
Q51801549 | Evaluation of sham non-invasive ventilation for randomized, controlled trials in ALS. |
Q36143045 | Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population |
Q73819705 | H-reflex changes in the course of amyotrophic lateral sclerosis |
Q35058671 | Intermittent hypoxia can aggravate motor neuronal loss and cognitive dysfunction in ALS mice |
Q92863328 | Intralingual and Intrapleural AAV Gene Therapy Prolongs Survival in a SOD1 ALS Mouse Model |
Q74841363 | Long-term mechanical ventilation in amyotrophic lateral sclerosis |
Q64087673 | Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions |
Q34530167 | Management of motor neurone disease |
Q34649259 | Outcome of ventilatory support for acute respiratory failure in motor neurone disease |
Q90449530 | Pattern of lung function decline in patients with amyotrophic lateral sclerosis: implications for timing of noninvasive ventilation |
Q55004580 | Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. |
Q33694106 | Practice parameter: The care of the patient with amyotrophic lateral sclerosis (An evidence-based review). |
Q30407658 | Predicting Early Bulbar Decline in Amyotrophic Lateral Sclerosis: A Speech Subsystem Approach |
Q36447824 | Prognostic factors in ALS: A critical review |
Q73128601 | Pulmonary evaluation and prevalence of non-invasive ventilation in patients with amyotrophic lateral sclerosis: a multicenter survey and proposal of a pulmonary protocol |
Q34490602 | Pulmonary function testing in neuromuscular disease |
Q34558955 | Pulmonary function tests in patients with amyotrophic lateral sclerosis and the association between these tests and survival |
Q35449456 | Respiratory aspects of neurological disease |
Q33745573 | Respiratory function in amyotrophic lateral sclerosis patients. The role of sleep studies. |
Q37307518 | Respiratory training in an individual with amyotrophic lateral sclerosis |
Q73321343 | Series 4: respiratory muscles in neuromuscular diseases and the chest cavity. The function of respiratory muscles in neuromuscular diseases |
Q37234667 | Skeletal muscle denervation causes skeletal muscle atrophy through a pathway that involves both Gadd45a and HDAC4. |
Q37976297 | Sleep-disordered breathing in neurodegenerative diseases |
Q43828824 | Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis |
Q92360470 | The Respiratory Phenotype of Rodent Models of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia |
Q24813305 | The cost-effectiveness of early noninvasive ventilation for ALS patients. |
Q34523766 | Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study |
Q81797022 | [Management and treatment of respiratory failure associated with amyotrophic lateral sclerosis] |
Q83060840 | [Neuromuscular disorders - assessment of the respiratory muscles] |
Q79805898 | [Review of nutritional and respiratory support in ALS] |
Search more.